Michiana Hematology/Oncology P.C.
South Bend, Indiana 46628
0 studies enrolling now · 24 studies all time
What they study most
Bladder Cancer, Cancer and Chemotherapy Related Anemia, Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma
Studies at this site
- Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer® — Completed
- First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
- Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer — Completed
- Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer — Withdrawn before enrolling
- Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer — Completed
- Oxaliplatin in Treating Patients With Metastatic Bladder Cancer — Completed
- O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma — Completed
- SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
- PS-341 in Treating Patients With Metastatic Kidney Cancer — Completed
- ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck — Completed
- BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer — Completed
- Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus — Completed
- SU5416 in Treating Patients With Malignant Mesothelioma — Completed
- SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer — Stopped early
- O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma — Completed
- Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer — Completed
- Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach — Completed
- Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer — Completed
- Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer — Completed
- Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma — Completed
- Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy — Completed
- BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment — Status unconfirmed
- Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus — Status unconfirmed
- Clinical Trial for Ovarian Cancer (OvaRex®) — Stopped early